|
EBAG9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.323000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.804000E-02 |
| Normal-vs-Stage2 |
2.828600E-01 |
| Normal-vs-Stage3 |
8.842000E-02 |
| Normal-vs-Stage4 |
2.433000E-01 |
| Stage1-vs-Stage2 |
7.983800E-01 |
| Stage1-vs-Stage3 |
9.461200E-01 |
| Stage1-vs-Stage4 |
4.353800E-02 |
| Stage2-vs-Stage3 |
8.140800E-01 |
| Stage2-vs-Stage4 |
7.496400E-02 |
| Stage3-vs-Stage4 |
2.406400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.179820E-02 |
| Normal-vs-AfricanAmerican |
3.560400E-02 |
| Normal-vs-Asian |
9.596400E-01 |
| Caucasian-vs-AfricanAmerican |
9.821200E-01 |
| Caucasian-vs-Asian |
7.233200E-01 |
| AfricanAmerican-vs-Asian |
7.219200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.303400E-03 |
| Normal-vs-Female |
1.787020E-01 |
| Male-vs-Female |
2.983800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.784300E-02 |
| Normal-vs-Extreme_Weight |
5.461600E-02 |
| Normal-vs-Obese |
1.250190E-01 |
| Normal-vs-Extreme_Obese |
2.459800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.559000E-01 |
| Normal_Weight-vs-Obese |
5.347000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.474000E-01 |
| Extreme_Weight-vs-Obese |
7.378400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.115400E-01 |
| Obese-vs-Extreme_Obese |
6.577800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.010600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.113960E-01 |
| Normal-vs-Age(61-80Yrs) |
5.626000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.091400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.403400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.702640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.623000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.146300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.337200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.799800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.591830E-02 |
| Normal-VS-Type2 PRCC |
1.204720E-03 |
| Normal-VS-KIRP CIMP |
6.373600E-01 |
| Normal-VS-Unclassified PRCC |
2.244600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.131600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.349400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.708400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.696600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.808200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.556600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.102200E-03 |
| Normal-vs-N1 |
8.996000E-01 |
| Normal-vs-N2 |
7.052800E-01 |
| N0-vs-N1 |
7.196400E-02 |
| N0-vs-N2 |
4.315000E-01 |
| N1-vs-N2 |
8.942800E-01 |
|
|
